Podcast thumbnail for Post-Hoc Live

Post-Hoc Live

Claim This Podcast

by Endpoints News

5.0(4 reviews)
48 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
47

Podcast Authority

Beta
FairBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality64
Social0
YouTube76
Engagement0

Podcast Overview

Post-Hoc Live is an extension of Endpoints' analysis newsletter Post-Hoc — but streamed live on YouTube then brought to you here. Our reporters spend every day texting and calling sources, reading executive orders, and talking to each other in Slack. We're bringing that analysis that happens behind the scenes directly to you, and letting you in on some of our up-to-the-moment conversations. Subscribe to Endpoints and the Post-Hoc newsletter here: https://profile.endpoints.news/create-account. Send us an email at: posthoclive@endpointsnews.com

Language

🇺🇲

Publishing Since

6/11/2025

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

47

Podcast Authority

Beta
FairBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality64
Social0
YouTube76
Engagement0
7
Excellent Areas
1
Good Performance
11
Growth Opportunities
excellent
Publishing Consistency
Every 5 days
Performing excellently!
good
Show Notes Quality
3.0/5

Recommendations available

Unlock the full report to see detailed tips

poor
Episode Thumbnails

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

Reach the team behind Post-Hoc Live

Verified contact details for this show aren't on file yet — sign up to get notified when they land.

Recent Episodes

Episode thumbnail for Live from Boston: How pharma thinks about China

August 7, 2026

Live from Boston: How pharma thinks about China

<p>As large pharma companies increasingly turn to China to fill their pipelines, what long-term affect will it have on their strategy and operations? Pfizer&#39;s Andrew Baum shares the large drugmaker perspective on acquisitions, R&amp;D, and how the industry could change in the years to come.Live from Endpoints’ <a href="https://events.endpoints.news/the-china-biotech-debate-boston/" target="_blank" rel="noopener noreferrer">China Biotech Debate: Boston</a> on August 6, 2026.</p><p><br></p>

Episode thumbnail for Live from Boston: Investor math versus industrial priority

August 7, 2026

Live from Boston: Investor math versus industrial priority

<p>Should investors embrace China’s fast-moving, fast-growing biotech sector, or should there be barriers to protect and preserve an industry that the US has dominated for decades? Ginkgo Bioworks CEO Jason Kelly, RA Capital Management&#39;s Peter Kolchinsky, and MIT professor Fiona Murray debate all sides of the flashpoint issue.Live from Endpoints’ <a href="https://events.endpoints.news/the-china-biotech-debate-boston/" target="_blank" rel="noopener noreferrer">China Biotech Debate: Boston</a> on August 6, 2026.</p><p><br></p>

Episode thumbnail for Live from Boston: Has China changed how we build companies?

August 7, 2026

Live from Boston: Has China changed how we build companies?

<p>In a world where promising drugs are quickly copied, improved on and raced into trials, is science still a differentiator? Strand Therapeutics CEO Jake Becraft and Roivant Sciences CEO Matt Gline discussed what actually counts as innovation, and if where the innovation happens matters for how the industry brings programs to patients. Live from Endpoints’ <a href="https://events.endpoints.news/the-china-biotech-debate-boston/" target="_blank" rel="ugc noopener noreferrer">China Biotech Debate: Boston</a> on August 6, 2026.</p>

48 total episodes available

Recent guests on Post-Hoc Live

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Industry experts

Guest

industry leaders

Guest

Andrew Dunn

Guest

Abhi Mahajan

Guest

Mandy Cohen

Guest

John Carroll

Guest

Kyle LaHucik

Guest

Nick Shipley

Guest

Deep-dive analytics for Post-Hoc Live

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Post-Hoc Live?

Post-Hoc Live is an extension of Endpoints' analysis newsletter Post-Hoc — but streamed live on YouTube then brought to you here. Our reporters spend every day texting and calling sources, reading executive orders, and talking to each other in Slack. We're bringing that analysis that happens behind the scenes directly to you, and letting you in on some of our up-to-the-moment conversations.

Subscribe to Endpoints and the Post-Hoc newsletter here: https://profile.endpoints.news/create-account. Send us an email at: posthoclive@endpointsnews.com

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.